NEW YORK (GenomeWeb) – Optivia Biotechnologies and cell-based assays firm Hurel today announced they have reached a technology and marketing alliance..

The partnership will give researchers an array of powerful tools for in vitro studies of hepatic clearance and drug-induced liver injury, the firms said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.